# A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

> clinical trial · VERIFIED · 2026-08-18

Status: RECRUITING · Sponsor: Normunity AccelCo, Inc. · Condition: HNSCC

- Company: Normunity AccelCo, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07182149

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.